Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

Agonists of the nuclear receptor PPARγ are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes. In spite of being effective in normalization of blood glucose levels, the currently used PPARγ agonists from the thiazolidinedione type have serious si...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang, Limei, Waltenberger, Birgit, Pferschy-Wenzig, Eva-Maria, Blunder, Martina, Liu, Xin, Malainer, Clemens, Blazevic, Tina, Schwaiger, Stefan, Rollinger, Judith M., Heiss, Elke H., Schuster, Daniela, Kopp, Brigitte, Bauer, Rudolf, Stuppner, Hermann, Dirsch, Verena M., Atanasov, Atanas G.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier Science 2014
Materias:
Part of the Special Issue: Metabolism 2014 – Alterations of metabolic pathways as therapeutic targets
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212005/
https://ncbi.nlm.nih.gov/pubmed/25083916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2014.07.018
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares